RhumbLine Advisers’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $355K | Buy |
17,207
+251
| +1% | +$5.19K | ﹤0.01% | 2891 |
|
|
2025
Q1 | $332K | Buy |
16,956
+532
| +3% | +$10.4K | ﹤0.01% | 2827 |
|
|
2024
Q4 | $343K | Sell |
16,424
-2,430
| -13% | -$50.7K | ﹤0.01% | 2907 |
|
|
2024
Q3 | $460K | Buy |
18,854
+160
| +0.9% | +$3.9K | ﹤0.01% | 2749 |
|
|
2024
Q2 | $470K | Buy |
18,694
+1,236
| +7% | +$31.1K | ﹤0.01% | 2727 |
|
|
2024
Q1 | $522K | Buy |
17,458
+1,602
| +10% | +$47.9K | ﹤0.01% | 2641 |
|
|
2023
Q4 | $505K | Sell |
15,856
-385
| -2% | -$12.3K | ﹤0.01% | 2655 |
|
|
2023
Q3 | $573K | Buy |
16,241
+311
| +2% | +$11K | ﹤0.01% | 2534 |
|
|
2023
Q2 | $605K | Buy |
+15,930
| New | +$605K | ﹤0.01% | 2571 |
|
|
2021
Q1 | – | Sell |
-5,677
| Closed | -$231K | – | 3001 |
|
|
2020
Q4 | $231K | Buy |
+5,677
| New | +$231K | ﹤0.01% | 2776 |
|